The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.65BCNY
546.93M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
365.73MCNY
54.82M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-7.78%
Updated Oct 21, 2026
Beta
0.9990x
vs all stocks
Updated Oct 21, 2026
52-Week Change
18.90%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
3.65BCNY
546.93M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
3.27BCNY
489.59M · vs all stocks (USD)
Updated Oct 21, 2026
Price to Sales (TTM)
9.52x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 9.98×.Updated Oct 21, 2026
Price to Book (MRQ)
8.24x
Updated Oct 21, 2026
Enterprise to Revenue
8.93x
Updated Oct 21, 2026
Enterprise to EBITDA
-165.36x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 396.37×.Updated Oct 21, 2026
Gross Margin
31.98%
Updated Oct 21, 2026
Profit Margin
-7.78%
Updated Oct 21, 2026
Operating Margin
-21.51%
Updated Oct 21, 2026
Return on Assets (TTM)
-2.21%
Updated Oct 21, 2026
Return on Equity (TTM)
-5.04%
Updated Oct 21, 2026
Revenue (TTM)
365.73MCNY
54.82M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
5.04CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
10.40%
Updated Oct 21, 2026
Gross Profit (TTM)
119.57MCNY
17.92M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
8.24MCNY
1.24M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-28.46MCNY
-4.27M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
175.04%
Updated Oct 21, 2026
Operating Cash Flow (TTM)
-18.14MCNY
-2.72M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-14.70MCNY
-2.20M · vs all stocks (USD)
Updated Oct 21, 2026
Payout Ratio
55.14%
Updated Oct 21, 2026
Minority Interest (Equity)
39.63MCNYFY2025 · Dec 31, 2025
Revenue
362.23MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
242.48MCNYFY2025 · Dec 31, 2025
Gross Profit
119.75MCNYFY2025 · Dec 31, 2025
Operating Income
-11.65MCNY
-1.75M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-32.21MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.80MCNYFY2025 · Dec 31, 2025
Net Income
-35.00MCNYFY2025 · Dec 31, 2025
EBIT
-31.79MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
8.24MCNYFY2025 · Dec 31, 2025
Research & Development
45.89MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
24.39MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
1.71MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.21MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
421.62KCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.5400CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.5400CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
72.42MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
72.42MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-35.00MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-4.10MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-49.48MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-51.80MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
315.84MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-35.00MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.08MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-8.21MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-7.34MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-2.32MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-20.57MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-22.50KCNYFY2025 · Dec 31, 2025
Sale of Investments
3.12MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-15.50MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-35.30MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
24.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-19.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-418.15KCNYFY2025 · Dec 31, 2025
Other Financing Charges
-8.44MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-3.86MCNYFY2025 · Dec 31, 2025
Shares Outstanding
72.04MSharesUpdated Oct 21, 2026
Float Shares
31.72MSharesUpdated Oct 21, 2026
% Held by Insiders
64.27%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
0.82%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
284.65MCNY
42.67M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
3.95CNYUpdated Oct 21, 2026
Total Debt (MRQ)
33.13MCNY
4.97M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0720x
Updated Oct 21, 2026
Current Ratio (MRQ)
3.41x
Updated Oct 21, 2026
Book Value per Share (MRQ)
5.87CNYUpdated Oct 21, 2026
Total Assets
673.59MCNY
100.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
556.59MCNYFY2025 · Dec 31, 2025
Total Liabilities
183.99MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
117.00MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
11.17MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
172.81MCNYFY2025 · Dec 31, 2025
Cash
315.84MCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.54MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
317.38MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
18.39MCNYFY2025 · Dec 31, 2025
Accounts Receivable
155.63MCNYFY2025 · Dec 31, 2025
Inventory
54.04MCNYFY2025 · Dec 31, 2025
Accounts Payable
57.93MCNYFY2025 · Dec 31, 2025
Short-term Debt
26.98MCNYFY2025 · Dec 31, 2025
Long-term Debt
9.47MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
72.04MCNYFY2025 · Dec 31, 2025
Retained Earnings
-15.88MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
489.60MCNY
73.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
39.80CNYUpdated Oct 21, 2026
52-Week High
99.50CNYUpdated Oct 21, 2026
52-Week Change
18.90%
vs all stocks
Updated Oct 21, 2026
Beta
0.9990x
vs all stocks
Updated Oct 21, 2026
50-Day MA
52.17CNYUpdated Oct 21, 2026
200-Day MA
61.11CNYUpdated Oct 21, 2026
Avg 10-Day Volume
1.70MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
1.68MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-0.3900CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.51
Altman Z-Score 12.93: safe zoneNotable
Altman Z-Score: 12.93
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.